“…Besides the increased activity of plasma acid phosphatase in Gaucher disease, there is also a well-known hyperactivity of angiotensin-converting enzyme (Liebermann and Beutler 1976;Silverstein and Friedland 1977;Van Sande et al 1986) and certain glycosidases (Ockerman and Kohlin 1969). We have confirmed these observations, since many glycosidases in Gaucher plasma have increased activity, the highest being hexosaminidase (2.5 times normal).…”
Section: Discussionsupporting
confidence: 82%
“…The samples were stored at -20°C to -35°C. Seven patients with Gaucher disease were described previously (Van Sande et al 1986). MU-TACT hydrolase activity was determined as described (Den Tandt et al 1988) or using a scaled-down micromethod, as follows: 15#1 0.25mmol/L MU-TACT, 5/A 1 mol/L sodium acetate buffer, pH 5.5, and 20#1 acidified plasma (Den Tandt et al 1974) were incubated for 15 and 30rain at 37°C.…”
Methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity was increased 53- to 484-fold in plasma from Gaucher disease patients and no activator could be found. High activity was also measured in other lysosomal storage diseases including Krabbe disease, Wolman disease, GM1-gangliosidosis and to a lesser extent Niemann-Pick disease type B, but the activities were lower than the lowest values in Gaucher patients. Kinetic properties of the high activity in Gaucher plasma were similar to those of controls. It is not known whether the increased activity represents intrinsic enzyme activity or increased enzyme concentration. It is possible that this enzyme may help in the detection of Gaucher disease or in the assessment of enzyme therapy with beta-D-glucosidase (Ceredase).
“…Besides the increased activity of plasma acid phosphatase in Gaucher disease, there is also a well-known hyperactivity of angiotensin-converting enzyme (Liebermann and Beutler 1976;Silverstein and Friedland 1977;Van Sande et al 1986) and certain glycosidases (Ockerman and Kohlin 1969). We have confirmed these observations, since many glycosidases in Gaucher plasma have increased activity, the highest being hexosaminidase (2.5 times normal).…”
Section: Discussionsupporting
confidence: 82%
“…The samples were stored at -20°C to -35°C. Seven patients with Gaucher disease were described previously (Van Sande et al 1986). MU-TACT hydrolase activity was determined as described (Den Tandt et al 1988) or using a scaled-down micromethod, as follows: 15#1 0.25mmol/L MU-TACT, 5/A 1 mol/L sodium acetate buffer, pH 5.5, and 20#1 acidified plasma (Den Tandt et al 1974) were incubated for 15 and 30rain at 37°C.…”
Methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity was increased 53- to 484-fold in plasma from Gaucher disease patients and no activator could be found. High activity was also measured in other lysosomal storage diseases including Krabbe disease, Wolman disease, GM1-gangliosidosis and to a lesser extent Niemann-Pick disease type B, but the activities were lower than the lowest values in Gaucher patients. Kinetic properties of the high activity in Gaucher plasma were similar to those of controls. It is not known whether the increased activity represents intrinsic enzyme activity or increased enzyme concentration. It is possible that this enzyme may help in the detection of Gaucher disease or in the assessment of enzyme therapy with beta-D-glucosidase (Ceredase).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.